What does this procedure involve?

This therapy involves three intravenous infusions of umbilical cord-derived mesenchymal stem cells (UC-MSCs) administered biweekly over six weeks. Each infusion delivers a controlled dose of stem cells that are expanded in a GMP-compliant laboratory to ensure purity and potency. The cells are thawed, washed, and infused over approximately 30–60 minutes, with vital signs monitored throughout. The aim is to modulate the immune system and reduce inflammation in refractory systemic lupus erythematosus (SLE).